153 related articles for article (PubMed ID: 3922561)
21. Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment.
Luthman J; Fredriksson A; Lewander T; Jonsson G; Archer T
Psychopharmacology (Berl); 1989; 99(4):550-7. PubMed ID: 2594922
[TBL] [Abstract][Full Text] [Related]
22. Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system.
Spyraki C; Fibiger HC; Phillips AG
Psychopharmacology (Berl); 1983; 79(2-3):278-83. PubMed ID: 6405439
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of the angiotensin II effects on the exploratory behavior of rats in open field. I. Interaction of angiotensin II with saralasin and catecholaminergic drugs.
Georgiev V; Getova D; Opitz M
Methods Find Exp Clin Pharmacol; 1987 May; 9(5):297-301. PubMed ID: 3613758
[TBL] [Abstract][Full Text] [Related]
24. The most desirable conformation of phenylethylamine (PEA) moiety stimulating noradrenergic neurons: effects of PEA, methamphetamine, phenelzine, methylphenidate, nomifensine and mazindol on rat spinal reflexes.
Hasebe Y; Ono H; Fukuda H; Ohta S; Hirobe M
Gen Pharmacol; 1989; 20(3):375-9. PubMed ID: 2744402
[TBL] [Abstract][Full Text] [Related]
25. Dopaminergic properties of nomifensine.
Gianutsos G; Morrow G; Light S; Sweeney MJ
Pharmacol Biochem Behav; 1982 Nov; 17(5):951-4. PubMed ID: 6294689
[TBL] [Abstract][Full Text] [Related]
26. A role for dopamine in growth hormone regulation in the dog.
Casanueva F; Betti R; Cocchi D; Zanardi P; Motta T; Müller EE
Endocrinology; 1981 Apr; 108(4):1469-75. PubMed ID: 7472276
[TBL] [Abstract][Full Text] [Related]
27. The influence of amphetamine and nomifensine on the development of morphine tolerance in the test of hypermotility in mice and catalepsy in rats.
Fidecka S; Langwiński R
Pol J Pharmacol Pharm; 1983; 35(6):503-10. PubMed ID: 6687158
[TBL] [Abstract][Full Text] [Related]
28. Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984).
Braestrup C; Scheel-Krüger J
Eur J Pharmacol; 1976 Aug; 38(2):305-12. PubMed ID: 986308
[TBL] [Abstract][Full Text] [Related]
29. Carbamazepine, phenytoin and phenobarbital do not influence brain catecholamine uptake, in vivo, in male rats.
Quattrone A; Annunziato L; Aguglia U; Preziosi P
Arch Int Pharmacodyn Ther; 1981 Aug; 252(2):180-5. PubMed ID: 7305556
[TBL] [Abstract][Full Text] [Related]
30. Noradrenergic involvement in catalepsy induced by delta 9-tetrahydrocannabinol.
Kataoka Y; Ohta H; Fujiwara M; Oishi R; Ueki S
Neuropharmacology; 1987 Jan; 26(1):55-60. PubMed ID: 3031535
[TBL] [Abstract][Full Text] [Related]
31. Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning.
Davids E; Zhang K; Tarazi FI; Baldessarini RJ
Psychopharmacology (Berl); 2002 Feb; 160(1):92-8. PubMed ID: 11862378
[TBL] [Abstract][Full Text] [Related]
32. Involvement of norepinephrine neurons in the hypothermia induced by intracerebroventricular administration of 6-hydroxydopamine in mice, evidenced by antidepressants.
Leroux-Nicollet I; Panissaud C; Costentin J
J Neural Transm; 1988; 74(1):17-27. PubMed ID: 2971783
[TBL] [Abstract][Full Text] [Related]
33. Involvement of amygdaloid catecholaminergic mechanism in suppressive effects of desipramine and imipramine on duration of immobility in rats forced to swim.
Araki H; Kawashima K; Uchiyama Y; Aihara H
Eur J Pharmacol; 1985 Jul; 113(3):313-8. PubMed ID: 3930265
[TBL] [Abstract][Full Text] [Related]
34. Effect of two indirectly acting dopamine agonists on prolactin secretion in normo- and hyperprolactinemic subjects: comparison with the effect of nomifensine.
Camanni F; Genazzani AR; de Leo V; Molinatti GM; Campagnoli C; Cocchi D; Müller EE
Neuroendocrinology; 1981 Nov; 33(5):300-5. PubMed ID: 7301051
[No Abstract] [Full Text] [Related]
35. A role for the mesolimbic dopamine system in the reinforcing properties of diazepam.
Spyraki C; Fibiger HC
Psychopharmacology (Berl); 1988; 94(1):133-7. PubMed ID: 3126522
[TBL] [Abstract][Full Text] [Related]
36. Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine.
O'Donnell JM; Seiden LS
J Pharmacol Exp Ther; 1984 Jun; 229(3):629-35. PubMed ID: 6427446
[TBL] [Abstract][Full Text] [Related]
37. Influence of nomifensine and desipramine on tyramine pressor responses in healthy volunteers.
McEwen J
Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):157S-158S. PubMed ID: 911649
[TBL] [Abstract][Full Text] [Related]
38. Abolition of nomifensine-induced stereotypy after 6-hydroxydopamine lesions of ascending dopaminergic projections.
Price MT; Fibiger HC
Pharmacol Biochem Behav; 1976 Aug; 5(2):107-9. PubMed ID: 1033565
[TBL] [Abstract][Full Text] [Related]
39. Dopaminergic involvement in the hyperalgesic effect of nomifensine.
Gonzalez JP; Sewell RD; Spencer PS
Life Sci; 1981 Feb; 28(8):951-6. PubMed ID: 7219061
[No Abstract] [Full Text] [Related]
40. The involvement of catecholaminergic mechanisms in the appearance of wet dog shakes produced by carbachol chloride in rats.
Turski W; Czuczwar SJ; Turski L; Kleinrok Z
Arch Int Pharmacodyn Ther; 1982 Feb; 255(2):204-11. PubMed ID: 6280627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
